Cash flow Kirin Holdings Company, Limited

Equities

2503

JP3258000003

Brewers

Delayed Japan Exchange Other stock markets 06:30:00 10/02/2026 GMT			5-day change	1st Jan Change
2,499.50 ^JPY	+2.56%		+6.84%	+6.45%

02-10	Kirin Holdings Company, Limited and Immunosens Co., Ltd. Launch Joint Development of a Self- Testing Service That Uses Urinary IgA to Visualize a Person's Immune Status	CI
02-06	Kirin to Sell Four Roses Distillery to E. & J. Gallo Winery -- Update	DJ

f0d9ec5.RtUwHqXXIkiVRoYEt9T2bRss8D-oXFoMZ-H8Qxpe6q0.NrpSKtPnRirPdeAy7bK4CmhhuA7vDiNmNYOfbnYZrMIwmFVrzeMUBMN08Q

Published financial data: KIRIN HOLDINGS COMPANY, LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1,850B	1,822B	1,989B	2,134B	2,338B
Other Revenues, Total	-	-	-	-	-
Total Revenues	1,850B	1,822B	1,989B	2,134B	2,338B
Cost of Goods Sold, Total	1,046B	999B	1,084B	1,171B	1,272B
Gross Profit	804B	823B	906B	963B	1,066B
Selling General & Admin Expenses, Total	642B	550B	598B	634B	689B
R&D Expenses	-	69.61B	74.27B	84.9B	116B
Depreciation & Amortization - (IS)	-	38.19B	41.86B	42.67B	49.99B
Other Operating Expenses	22.13B	18.97B	25.82B	17.32B	20.51B
Other Operating Expenses, Total	664B	676B	740B	779B	876B
Operating Income	140B	146B	165B	184B	190B
Interest Expense, Total	-4.89B	-4.45B	-4.89B	-5.93B	-6.92B
Interest And Investment Income	2.75B	2.72B	4.5B	4.73B	13.22B
Net Interest Expenses	-2.14B	-1.73B	-397M	-1.2B	6.3B
Income (Loss) On Equity Invest.	24.75B	34.49B	22.78B	32.77B	37.04B
Currency Exchange Gains (Loss)	-1.2B	876M	5.28B	4.31B	1.38B
Other Non Operating Income (Expenses)	217M	-2.1B	-385M	-4.59B	-895M
EBT, Excl. Unusual Items	162B	178B	193B	215B	234B
Restructuring Charges	-7.09B	-2.03B	-742M	-2.78B	-37.4B
Merger & Related Restructuring Charges	-86M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	23M	48.09B	10.93B	-30.15B
Gain (Loss) On Sale Of Assets	-271M	1.02B	4.47B	3.36B	-3.43B
Asset Writedown	-29.62B	-77.39B	-53.05B	-29.92B	-23.57B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	125B	99.62B	191B	197B	140B
Income Tax Expense	24.71B	31.19B	47.62B	46.61B	53.91B
Earnings From Continuing Operations	99.84B	68.42B	144B	150B	85.81B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	99.84B	68.42B	144B	150B	85.81B
Minority Interest	-27.91B	-8.63B	-32.76B	-37.74B	-27.6B
Net Income - (IS)	71.94B	59.79B	111B	113B	58.21B
Net Income to Common Incl Extra Items	71.94B	59.79B	111B	113B	58.21B
Net Income to Common Excl. Extra Items	71.94B	59.79B	111B	113B	58.21B
Per Share Items
Net EPS - Basic	85.57	71.73	135.09	139.16	71.87
Basic EPS - Continuing Operations	85.57	71.73	135.09	139.16	71.87
Basic Weighted Average Shares Outstanding	841M	834M	822M	810M	810M
Net EPS - Diluted	85.54	71.7	135.07	139.15	71.86
Diluted EPS - Continuing Operations	85.54	71.7	135.07	139.15	71.86
Diluted Weighted Average Shares Outstanding	841M	834M	822M	810M	810M
Normalized Basic EPS	86.96	123.09	106.63	119.68	146.71
Normalized Diluted EPS	86.96	123.09	106.63	119.68	146.71
Dividend Per Share	65	65	69	71	71
Payout Ratio	76.91	90.62	48.45	51.02	100.18
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	198B	228B	251B	271B	286B
EBITA	149B	146B	165B	184B	190B
EBIT	140B	146B	165B	184B	190B
EBITDAR	203B	-	-	-	-
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	19.84	31.31	24.88	23.65	38.58
Total Current Taxes	30.33B	-	-	-	-
Total Deferred Taxes	-5.62B	-	-	-	-
Normalized Net Income	73.1B	103B	87.62B	96.92B	119B
Interest on Long-Term Debt	1.46B	-	-	-	-
Non-Cash Pension Expense	-	15.85B	16.49B	16.63B	18.78B
Supplemental Operating Expense Items
Advertising Expense	150B	163B	166B	166B	169B
Selling and Marketing Expenses	150B	222B	225B	221B	231B
Research And Development Expense From Footnotes	78.94B	69.6B	74.3B	84.9B	116B
Net Rental Expense, Total	4.48B	-	-	-	-
Imputed Operating Lease Interest Expense	264M	-	-	-	-
Imputed Operating Lease Depreciation	4.22B	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	28M	-	-	-	-
Total Stock-Based Compensation	28M	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	162B	149B	88.06B	131B	119B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	162B	149B	88.06B	131B	119B
Accounts Receivable, Total	372B	388B	409B	445B	503B
Total Receivables	372B	388B	409B	445B	503B
Inventory	217B	247B	290B	331B	359B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	116B	41.98B	99.62B	50.5B	60.71B
Total Current Assets	867B	827B	887B	958B	1,041B
Gross Property Plant And Equipment	1,731B	-	-	-	-
Accumulated Depreciation	-1,209B	-	-	-	-
Net Property Plant And Equipment	522B	534B	561B	593B	674B
Long-term Investments	387B	542B	493B	515B	368B
Goodwill	246B	264B	290B	391B	501B
Other Intangibles, Total	209B	196B	201B	304B	660B
Deferred Tax Assets Long-Term	102B	109B	111B	109B	110B
Other Long-Term Assets, Total	127B	-	-	-	1M
Total Assets	2,459B	2,472B	2,542B	2,870B	3,354B
Liabilities
Accounts Payable, Total	159B	230B	265B	307B	364B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	-	82.06B	20.51B	701M	13.01B
Current Portion of Long-Term Debt	249B	19.44B	93.95B	99.97B	64.98B
Current Portion of Leases	17.99B	-	-	-	-
Current Income Taxes Payable	8.71B	22.16B	4.61B	9.69B	11.43B
Other Current Liabilities	303B	246B	240B	256B	290B
Total Current Liabilities	737B	599B	625B	673B	744B
Long-Term Debt	394B	450B	409B	556B	780B
Long-Term Leases	60.15B	-	-	-	-
Pension & Other Post Retirement Benefits	66.89B	61.95B	58.08B	55.23B	54.99B
Deferred Tax Liability Non Current	17.24B	10.61B	13.56B	38.87B	123B
Other Non Current Liabilities	88.06B	202B	184B	121B	119B
Total Liabilities	1,363B	1,324B	1,289B	1,444B	1,820B
Common Stock, Total	102B	102B	102B	102B	102B
Additional Paid In Capital	24.94B	25.1B	25.52B	21.15B	9.5B
Retained Earnings	981B	998B	1,064B	1,129B	1,131B
Treasury Stock	-202B	-202B	-252B	-252B	-251B
Comprehensive Income and Other	-67.52B	-29.35B	40.42B	133B	190B
Total Common Equity	839B	894B	980B	1,133B	1,182B
Minority Interest	257B	254B	273B	293B	352B
Total Equity	1,096B	1,148B	1,253B	1,426B	1,534B
Total Liabilities And Equity	2,459B	2,472B	2,542B	2,870B	3,354B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	834M	834M	810M	810M	810M
ECS Total Common Shares Outstanding	834M	834M	810M	810M	810M
Book Value / Share	1.01K	1.07K	1.21K	1.4K	1.46K
Tangible Book Value	384B	434B	490B	438B	20.48B
Tangible Book Value Per Share	460.15	520.18	604.57	541.41	25.29
Total Debt	721B	551B	523B	656B	858B
Net Debt	559B	402B	435B	525B	739B
Debt Equivalent of Unfunded Proj. Benefit Obligation	47.41B	40.8B	36.46B	24.31B	8.15B
Debt Equivalent Oper. Leases	35.86B	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	257B	254B	273B	293B	352B
Equity Method Investments, Total	387B	399B	362B	371B	216B
Account Code - Inventory Valuation	6	-	-	-	-
Inventories - Raw Materials, Total	44.79B	53.46B	57.84B	69.08B	79.27B
Inventories - Work In Process, Total	24.32B	27.86B	32.45B	33.18B	28.1B
Inventories - Finished Goods, Total	148B	166B	200B	229B	252B
Inventories - Others	-	-	-	1M	1M
Land - (BS)	81.61B	-	-	-	-
Buildings, Total	543B	-	-	-	-
Machinery, Total	1,074B	-	-	-	-
Full Time Employees	-	29.52K	30.54K	30.18K	31.93K
Accumulated Allowance for Doubtful Accounts (Supple)	1.53B	1.52B	1.46B	1.54B	1.65B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	71.94B	99.62B	191B	197B	140B
Depreciation & Amortization - CF	67.52B	81.13B	85.94B	87.23B	95.7B
Amortization of Goodwill and Intangible Assets - (CF)	8.62B	-	-	-	-
Depreciation & Amortization, Total	76.14B	81.13B	85.94B	87.23B	95.7B
Amortization of Deferred Charges, Total - (CF)	5.97B	-	-	-	-
(Gain) Loss From Sale Of Asset	33M	76.11B	48.11B	26.42B	14.6B
(Gain) Loss on Sale of Investments - (CF)	-	-23M	-48.09B	-10.93B	11.88B
Asset Writedown & Restructuring Costs	29.62B	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-24.75B	-34.49B	-22.78B	-32.77B	-37.04B
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	9.69B	-10.97B	-48.06B	-12.42B	-24.67B
Change In Accounts Receivable	3.78B	-9.11B	-8.46B	-13.36B	-34.89B
Change In Inventories	-6.08B	-20.35B	-39.49B	-20.06B	-4.89B
Change In Accounts Payable	-1.11B	3.51B	18.38B	10.97B	18.24B
Change in Other Net Operating Assets	-392M	33.88B	-41.38B	-28.9B	64.18B
Cash from Operations	165B	219B	136B	203B	243B
Capital Expenditure	-93.03B	-86.34B	-98.48B	-114B	-181B
Sale of Property, Plant, and Equipment	2.08B	6.98B	11.32B	7.46B	5.66B
Cash Acquisitions	-39.63B	-45.62B	-55.56B	-162B	-160B
Divestitures	18M	47.99B	122B	27.04B	4.86B
Investment in Marketable and Equity Securities, Total	16.91B	19.22B	5.46B	6.61B	3.39B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-2.34B	1.36B	4.61B	8.72B	-2.87B
Cash from Investing	-116B	-56.41B	-10.4B	-226B	-329B
Short Term Debt Issued, Total	28.36B	4.64B	-	-	13B
Long-Term Debt Issued, Total	195B	71B	91.85B	265B	297B
Total Debt Issued	223B	75.64B	91.85B	265B	310B
Short Term Debt Repaid, Total	-	-81.99B	-61.09B	-19.9B	-717M
Long-Term Debt Repaid, Total	-123B	-90B	-67.61B	-118B	-118B
Total Debt Repaid	-123B	-172B	-129B	-138B	-119B
Repurchase of Common Stock	-76.81B	-34M	-50.04B	-25M	-82M
Common Dividends Paid	-55.33B	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-54.18B	-53.78B	-57.5B	-58.32B
Common & Preferred Stock Dividends Paid	-55.33B	-54.18B	-53.78B	-57.5B	-58.32B
Other Financing Activities, Total	-20.57B	-29.89B	-27.16B	-32.72B	-74.63B
Cash from Financing	-52.47B	-180B	-168B	35.91B	58.12B
Foreign Exchange Rate Adjustments	-388M	5.39B	6.73B	4.83B	15.62B
Miscellaneous Cash Flow Adjustments	-	-	-25.48B	25.48B	-
Net Change in Cash	-4B	-12.18B	-61.43B	43.34B	-12.78B
Supplemental Items
Cash Interest Paid	4.79B	4.14B	4.37B	5.44B	6.52B
Cash Income Tax Paid (Refund)	54.64B	29.59B	68.82B	36.65B	50.81B
Levered Free Cash Flow	4.57B	138B	-21.43B	119B	27.62B
Unlevered Free Cash Flow	7.62B	141B	-18.37B	123B	31.94B
Change In Net Working Capital	68.98B	-54.74B	109B	-34.55B	2.21B
Net Debt Issued / Repaid	100B	-96.35B	-36.85B	126B	191B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.59	3.71	4.12	4.25	3.83
Return on Total Capital	4.9	5.21	5.95	5.97	5.32
Return On Equity %	8.9	6.1	11.97	11.23	5.8
Return on Common Equity	8.24	6.9	11.85	10.67	5.03
Margin Analysis
Gross Profit Margin %	43.46	45.17	45.53	45.14	45.58
SG&A Margin	34.7	30.17	30.08	29.72	29.46
EBITDA Margin %	10.73	12.49	12.63	12.72	12.24
EBITA Margin %	8.03	8.04	8.31	8.63	8.14
EBIT Margin %	7.57	8.04	8.31	8.63	8.14
Income From Continuing Operations Margin %	5.4	3.76	7.23	7.05	3.67
Net Income Margin %	3.89	3.28	5.58	5.28	2.49
Net Avail. For Common Margin %	3.89	3.28	5.58	5.28	2.49
Normalized Net Income Margin	3.95	5.63	4.4	4.54	5.08
Levered Free Cash Flow Margin	0.25	7.59	-1.08	5.59	1.18
Unlevered Free Cash Flow Margin	0.41	7.74	-0.92	5.77	1.37
Asset Turnover
Asset Turnover	0.76	0.74	0.79	0.79	0.75
Fixed Assets Turnover	3.42	3.45	3.64	3.7	3.69
Receivables Turnover (Average Receivables)	4.82	4.79	4.99	5	4.93
Inventory Turnover (Average Inventory)	4.79	4.3	4.03	3.77	3.69
Short Term Liquidity
Current Ratio	1.18	1.38	1.42	1.42	1.4
Quick Ratio	0.72	0.9	0.8	0.86	0.84
Operating Cash Flow to Current Liabilities	0.22	0.37	0.22	0.3	0.33
Days Sales Outstanding (Average Receivables)	75.97	76.15	73.12	73.03	74.18
Days Outstanding Inventory (Average Inventory)	76.37	84.86	90.5	96.81	99.23
Average Days Payable Outstanding	58.23	68.96	80.14	86.13	94.42
Cash Conversion Cycle (Average Days)	94.1	92.05	83.48	83.72	78.99
Long Term Solvency
Total Debt/Equity	65.77	48.04	41.74	46.04	55.91
Total Debt / Total Capital	39.67	32.45	29.45	31.52	35.86
LT Debt/Equity	41.4	39.2	32.61	38.98	50.83
Long-Term Debt / Total Capital	24.98	26.48	23.01	26.69	32.6
Total Liabilities / Total Assets	55.44	53.56	50.71	50.31	54.27
EBIT / Interest Expense	28.63	32.93	33.78	31.05	27.54
EBITDA / Interest Expense	44.2	51.17	51.34	45.75	41.38
(EBITDA - Capex) / Interest Expense	25.17	31.76	31.22	26.57	15.26
Total Debt / EBITDA	3.33	2.42	2.08	2.42	3
Net Debt / EBITDA	2.59	1.77	1.73	1.93	2.58
Total Debt / (EBITDA - Capex)	5.86	3.9	3.42	4.17	8.12
Net Debt / (EBITDA - Capex)	4.54	2.85	2.85	3.33	7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.73	-1.51	9.22	7.28	9.56
Gross Profit, 1 Yr. Growth %	-5.15	2.36	10.07	6.38	10.64
EBITDA, 1 Yr. Growth %	-12.19	14.68	10.41	8.01	5.44
EBITA, 1 Yr. Growth %	-16.62	-1.45	12.89	11.39	3.41
EBIT, 1 Yr. Growth %	-16.94	4.62	12.89	11.39	3.41
Earnings From Cont. Operations, 1 Yr. Growth %	22.6	-31.47	110.12	4.64	-42.96
Net Income, 1 Yr. Growth %	20.61	-16.88	85.66	1.52	-48.34
Normalized Net Income, 1 Yr. Growth %	-28.14	40.36	-14.61	10.61	22.6
Diluted EPS Before Extra, 1 Yr. Growth %	25.83	-16.18	88.37	3.02	-48.36
Accounts Receivable, 1 Yr. Growth %	-5.94	4.24	5.48	8.74	13.02
Inventory, 1 Yr. Growth %	-0.92	13.84	17.37	14.07	8.46
Net Property, Plant and Equip., 1 Yr. Growth %	-7.01	2.29	5.02	5.76	13.68
Total Assets, 1 Yr. Growth %	1.93	0.51	2.85	12.88	16.89
Tangible Book Value, 1 Yr. Growth %	-23.86	13.04	12.91	-10.44	-95.33
Common Equity, 1 Yr. Growth %	-7.5	6.63	9.6	15.57	4.32
Cash From Operations, 1 Yr. Growth %	-7.82	33.04	-38.19	49.9	19.51
Capital Expenditures, 1 Yr. Growth %	-3.5	-7.19	14.07	15.57	58.67
Levered Free Cash Flow, 1 Yr. Growth %	-94.41	2.93K	-115.49	-657.15	-76.86
Unlevered Free Cash Flow, 1 Yr. Growth %	-91.12	1.75K	-113.02	-770.12	-74.05
Dividend Per Share, 1 Yr. Growth %	1.56	0	6.15	2.9	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.12	-3.13	3.71	8.25	8.42
Gross Profit, 2 Yr. CAGR %	-1.78	-1.47	6.14	8.21	8.49
EBITDA, 2 Yr. CAGR %	-11.08	0.35	12.53	9.2	6.72
EBITA, 2 Yr. CAGR %	-13.95	-9.35	5.48	12.14	7.33
EBIT, 2 Yr. CAGR %	-12.54	-6.78	8.68	12.14	7.33
Earnings From Cont. Operations, 2 Yr. CAGR %	-28.48	-8.34	20	48.28	-22.74
Net Income, 2 Yr. CAGR %	-33.81	0.12	24.22	37.29	-27.58
Normalized Net Income, 2 Yr. CAGR %	-14.17	0.43	9.48	-2.81	16.45
Diluted EPS Before Extra, 2 Yr. CAGR %	-31.73	2.7	25.66	39.31	-27.06
Accounts Receivable, 2 Yr. CAGR %	-4.13	-0.98	4.86	7.1	10.86
Inventory, 2 Yr. CAGR %	2.97	6.2	15.59	15.71	11.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.49	-2.47	3.64	5.39	9.65
Total Assets, 2 Yr. CAGR %	3.32	1.22	1.67	7.74	14.86
Tangible Book Value, 2 Yr. CAGR %	-11.7	-7.22	12.98	0.56	-79.55
Common Equity, 2 Yr. CAGR %	-4.32	-0.69	8.1	12.54	9.8
Cash From Operations, 2 Yr. CAGR %	-8.77	10.74	-9.31	-3.74	33.84
Capital Expenditures, 2 Yr. CAGR %	2.88	-5.36	2.89	14.81	35.42
Levered Free Cash Flow, 2 Yr. CAGR %	-82.59	30.13	116.57	-7.09	13.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	-77.77	28.19	55.21	-6.6	31.88
Dividend Per Share, 2 Yr. CAGR %	12.89	0.78	3.03	4.51	1.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.25	-1.92	0.82	4.89	8.68
Gross Profit, 3 Yr. CAGR %	-0.36	-0.42	2.24	6.22	9.01
EBITDA, 3 Yr. CAGR %	-7.99	-3.21	3.6	11	7.93
EBITA, 3 Yr. CAGR %	-9.88	-9.97	-2.47	7.41	9.15
EBIT, 3 Yr. CAGR %	-9.01	-7.16	-0.64	9.58	9.15
Earnings From Cont. Operations, 3 Yr. CAGR %	-18.1	-29.49	20.86	14.64	7.84
Net Income, 3 Yr. CAGR %	-33.26	-28.59	23.01	16.14	-0.89
Normalized Net Income, 3 Yr. CAGR %	-11.1	1.12	-4.85	9.86	5.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-20.78	-26.9	25.72	17.61	0.07
Accounts Receivable, 3 Yr. CAGR %	-2.56	-1.42	1.13	6.14	9.04
Inventory, 3 Yr. CAGR %	3.63	6.47	9.8	15.08	13.24
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.8	0.43	-0.04	4.34	8.08
Total Assets, 3 Yr. CAGR %	0.84	2.38	1.76	5.28	10.71
Tangible Book Value, 3 Yr. CAGR %	-9.33	-4.12	-0.95	4.56	-63.85
Common Equity, 3 Yr. CAGR %	-4.34	-0.8	2.63	10.54	9.73
Cash From Operations, 3 Yr. CAGR %	-9.41	3.46	-8.82	7.22	3.46
Capital Expenditures, 3 Yr. CAGR %	1.55	-0.59	0.71	6.95	27.89
Levered Free Cash Flow, 3 Yr. CAGR %	-36.76	-2.83	-35.98	196.75	-41.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.88	-2.94	-40.19	152.73	-39.05
Dividend Per Share, 3 Yr. CAGR %	12.22	8.42	2.54	2.99	2.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.44	-0.35	1.31	2.03	3.79
Gross Profit, 5 Yr. CAGR %	-3.65	0.89	2.19	2.94	4.69
EBITDA, 5 Yr. CAGR %	-2.96	-1.95	-0.27	1.58	4.83
EBITA, 5 Yr. CAGR %	1.78	-5.88	-4.02	-1.7	1.34
EBIT, 5 Yr. CAGR %	5.18	-3.99	-2.31	0.13	2.47
Earnings From Cont. Operations, 5 Yr. CAGR %	28.5	-15.42	-4.58	-5.08	1.05
Net Income, 5 Yr. CAGR %	8.73	-16.68	-14.43	-7.25	-0.48
Normalized Net Income, 5 Yr. CAGR %	3.59	0.11	-3.38	-0.47	3.16
Diluted EPS Before Extra, 5 Yr. CAGR %	10.52	-14.2	-4.72	-5.39	1.12
Accounts Receivable, 5 Yr. CAGR %	-1.1	-2.23	0.34	1.9	4.91
Inventory, 5 Yr. CAGR %	-0.94	3.8	8.26	10.07	10.37
Net Property, Plant and Equip., 5 Yr. CAGR %	-6.02	-3.51	0.34	2.38	3.73
Total Assets, 5 Yr. CAGR %	0.13	0.4	1.17	4.49	6.81
Tangible Book Value, 5 Yr. CAGR %	13.27	12.08	-0.99	-2.28	-47.3
Common Equity, 5 Yr. CAGR %	4.77	4.84	0.46	4.33	5.44
Cash From Operations, 5 Yr. CAGR %	-0.73	-1.14	-9.37	0.52	6.31
Capital Expenditures, 5 Yr. CAGR %	3.82	-2.78	2.08	5.31	13.38
Levered Free Cash Flow, 5 Yr. CAGR %	-45.75	-0.45	3.47	-4.56	-19.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	-41.34	-0.67	-3.64	-4.42	-17.94
Dividend Per Share, 5 Yr. CAGR %	11.33	10.76	8.45	6.84	2.1